Drugs / Arverapamil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00552565 | Sep 2007 → Jun 2009 | irritable bowel syndrome | AGI Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arverapamil | “Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)” NCT00552565 ↗ |
| Known as | Rezular | “Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)” NCT00552565 ↗ |
| Route | Oral | “Oral Tablets” NCT00552565 ↗ |